Pantoprazolo Aurobindo (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazolo Aurobindo, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid secretion and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Pantoprazolo Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazolo Aurobindo, a proton pump inhibitor, is indicated for acid‑related gastrointestinal disorders. - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and esophageal irritation. - Peptic ulcer disease: promotes healing of gastric and duodenal ulcers. - Erosive oesophagitis: heals inflammation caused by acid exposure. - Zollinger‑Ellison syndrome: controls excessive gastric acid production.

Pantoprazolo Aurobindo may cause a range of adverse reactions.

Common Side Effects: - Headache: mild to moderate pain often resolving without treatment. - Diarrhoea: loose stools that may be self‑limiting. - Nausea: feeling of unease or upset stomach. - Abdominal pain: discomfort in the stomach region. - Flatulence: excess gas causing bloating. - Constipation: difficulty passing stools.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or anaphylaxis. - Clostridioides difficile infection: severe colitis with watery diarrhoea. - Hypomagnesemia: low magnesium levels leading to muscle cramps or arrhythmia. - Liver enzyme elevation: signs of hepatic stress. - Stevens‑Johnson syndrome: life‑threatening skin reaction. - Interstitial nephritis: kidney inflammation presenting with reduced urine output.

Before initiating therapy, consider the following safety measures. - Renal function assessment: adjust use in severe kidney disease. - Magnesium monitoring: check levels during prolonged treatment. - Hepatic impairment: use with caution in patients with liver disease. - Rebound acid hypersecretion: avoid abrupt discontinuation after long‑term use. - Drug interaction review: evaluate concomitant medications for potential conflicts. - Store at room temperature below 25°C: keep in the original packaging, protect from moisture.

Pantoprazolo Aurobindo can interact with several medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing clot risk. - Atazanavir: decreased absorption, lowering antiviral efficacy. - High‑dose methotrexate: increased toxicity due to reduced clearance.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of INR, requiring closer monitoring. - Diazepam: elevated plasma levels, enhancing sedation. - Digoxin: altered absorption, may affect cardiac monitoring.